title: Principles of immunapheresis and specific elimination of plasma components.
abstract: In summary the therapeutic use of affinity chromatography, the immunapheresis with LDL-Therasorb columns, Baxter, has been shown to be a safe, specific and efficacious extracorporeal treatment. Following GMP rules LDL-Therasorb is produced in a constant quality. Beyond the treatment of hypercholesterolemia the versatility of antibodies opens this technology to the treatment of other diseases.
authors.affiliation: Baxter Deutschland GmbH, Unterschleissheim.
authors.forename: R
authors.initials: R
authors.lastname: Spaethe
authors.forename: A
authors.initials: A
authors.lastname: du Moulin
authors.forename: F
authors.initials: F
authors.lastname: Bieber
authors.forename: W
authors.initials: W
authors.lastname: Böhm
mesh_terms: D000918:Antibody Specificity; D001781:Blood Component Removal / Q000379:methods*; D002784:Cholesterol / Q000302:isolation & purification*; D002846:Chromatography, Affinity; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000628:therapy*; D007163:Immunosorbent Techniques; D008077:Lipoproteins, LDL; D012307:Risk Factors; D012685:Sepharose
chemical_list: D008077:Lipoproteins, LDL; D012685:Sepharose; D002784:Cholesterol